Making medicines evergreen

BMJ (Online)

Volumn 345, Issue 7886, 2012, Pages

  Hitchings, Andrew W ^b   Baker, Emma H ^a   Khong, Teck K ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALENDRONIC ACID PLUS COLECALCIFEROL; AMOXICILLIN PLUS CLAVULANIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CARBONATE; CORTICOSTEROID; DESLORATADINE; DOXAZOSIN; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESOMEPRAZOLE; GABAPENTIN; GENERIC DRUG; LORATADINE; OMEPRAZOLE; ORAL CONTRACEPTIVE AGENT; PALIPERIDONE; PREGABALIN; RISPERIDONE; SILDENAFIL; SIMVASTATIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

COMMERCIAL PHENOMENA; COMPARATIVE EFFECTIVENESS; COST CONTROL; DOSE RESPONSE; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUSTRY; DRUG MARKETING; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; EVERGREEN; HUMAN; LICENCE; MEDICINE; PATENT; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT SURVEY; TREATMENT INDICATION; UNITED KINGDOM;

DRUG COSTS; DRUG INDUSTRY; DRUG PRESCRIPTIONS; DRUGS, GENERIC; GREAT BRITAIN; HUMANS;

EID: 84870709148     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e7941     Document Type: Short Survey

References (21)

1. Office of Health Economics. ABPI UK NHS medicines bill projection 2012 -15. www.abpi.org.uk/our-work/library/industry/Pages/medicines-bill-projection. aspx.
2. National Audit Office. Prescribing costs in primary care. Report by the comptroller and auditor general. HC 454 Session 2006-2007. Stationery Office, 2007. www.nao.org.uk/publications/0607/prescribing-costs-in-primary-c.aspx.
3. Rang HP, ed. Drug discovery and development. Elsevier, 2006.
4. Pammolli F. Is there a productivity crisis in pharmaceutical R&D? Office of Health Economics seminar briefing No 11, 2012. www.ohe.org/ publications/article/is-there-a-productivity-crisis-in-pharmaceutical-rd-118. cfm.
5. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010;9:203-14.
6. Health and Social Care Information Centre. Prescription cost analysis, England, 1998-2011. www.ic.nhs.uk/statistics-and-data-collections/primary-care/ prescriptions.
7. National Prescribing Centre. Generic prescribing in primary care. MeReC Bull 2011;21(3). www.npc.nhs.uk/merec/other-non-clinical/merec-bulletin-vol21- no3.php#INT.
8. Health and Social Care Information Centre. Prescriptions dispensed in the community: England, statistics for 1999 to 2009. www.ic.nhs.uk/pubs/presdisp99- 09.
9. Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. http://www.medicinescomplete.com.
10. Greene JA, Kesselheim AS. Why do the same drugs look different? Pills, trade dress, and public health. N Engl J Med 2011;365:83-9.
11. Is Yasmin a "truly different" pill? Drug Ther Bull 2002;40:57-9.
12. Yasmin advert withdrawn - why and how. Drug Ther Bull 2003;41:17-8.
13. New drugs from old. Drug Ther Bull 2006;44:73-7.
14. National Institute for Health and Clinical Excellence. Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. Clinical guideline 96. 2010. www.nice.org.uk/guidance/CG96.
15. Why pregabalin? Drug Ther Bull 2010;48:61.
16. General Medical Council. Good practice in prescribing medicines, 2008. www.gmc-uk.org/static/documents/content/Good-Practice-in-Prescribing-Medicines- 0911.pdf.
17. General Medical Council. Good practice in prescribing and managing medicines and devices. Draft for consultation, 2011. www.gmc-uk.org/Good- practice-prescribing-consultation-draft-FINAL.pdf-40006888.pdf.
18. Nussbaum AM, Stroup TS. Oral paliperidone for schizophrenia. Cochrane Database Syst Rev 2008;2:CD006369.
19. Nussbaum AM, Stroup TS. Paliperidone palmitate for schizophrenia. Cochrane Database Syst Rev 2012;6:CD008296.
20. Janssen Pharmaceuticals. Atypical antipsychotic medication - Invega (paliperidone) . www.janssencns.com/invega.
21. Schwartz LM, Woloshin S. How the FDA forgot the evidence: the case of donepezil 23 mg. BMJ 2012;344:e1086.